Highlighting the Issues Associated with Glaucoma Medication Therapy: A Pharmaceutical Care Evaluation
DOI:
https://doi.org/10.54133/ajms.v5i.149Keywords:
Pharmaceutical care, Glaucoma, Clinical pharmacist, Drug therapy problemsAbstract
Background: Drug therapy problems are the main obstacle in the management of chronic diseases. Improper use of medications and non-adherence to medication use are regarded as major factors halting the management of glaucoma. Aim: The present study was designed to shed light on the problems associated with medication therapy for patients with glaucoma in Sulaimani City. Method: A cross-sectional study was conducted on fifty patients with glaucoma. Questionnaires were used for demographic data, the patient’s quality of life, and adherence. Patients were assessed for dry eye by using Schirmer’s test type 1. Drug therapy problems (DTPs) and drug interactions were checked using the Medscape interaction database. Results: 60% of the patients were washing their hands before administering eye drops. The majority of patients had the correct position of the head during the administration. While 60% of the patients were closing their eyes after the administration for 2 or 3 minutes. Regarding adherence, only 24% of patients were perfectly adherent to medication use. Noncompliance with their treatments and adverse drug reactions were the most commonly observed DTPs. Thirty-seven of the patients had a metallic taste, and the most common type of drug interactions were significant interactions. Conclusion: The absence of pharmaceutical care has led to many problems associated with the improper use of antiglaucoma drugs. Pharmacists may play a pivotal role in improving the outcomes of patients with glaucoma.
Downloads
References
Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N. The diagnosis and treatment of glaucoma. Dtsch Arztebl Int. 2020;117(13):225. doi: 10.3238/ARZTEBL.2020.0225. DOI: https://doi.org/10.3238/arztebl.2020.0225
Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM. Inflammation in glaucoma: From the back to the front of the eye, and beyond. Prog Retin Eye Res. 2021;83. doi: 10.1016/J.PRETEYERES.2020.100916. DOI: https://doi.org/10.1016/j.preteyeres.2020.100916
Coyle S, Khan MN, Chemaly M, Callaghan B, Doyle C, Willoughby CE, et al. Targeting the NLRP3 inflammasome in glaucoma. Biomolecules. 2021;11(8):1239. doi: 10.3390/biom11081239. DOI: https://doi.org/10.3390/biom11081239
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901-1911. doi: 10.1001/JAMA.2014.3192. DOI: https://doi.org/10.1001/jama.2014.3192
Cohen LP, Pasquale LR. Clinical characteristics and current treatment of glaucoma. Cold Spring Harb Perspect Med. 2014;4(6). doi: 10.1101/CSHPERSPECT.A017236. DOI: https://doi.org/10.1101/cshperspect.a017236
Leshno A, Stern O, Barkana Y, Kapelushnik N, Singer R, Prat DL, et al. Ocular surface temperature differences in glaucoma. Eur J Ophthalmol. 2022;32(3):1518-1524. doi: 10.1177/11206721211023723. DOI: https://doi.org/10.1177/11206721211023723
Lem DW, Gierhart DL, Davey PG. Carotenoids in the management of glaucoma: A systematic Review of the evidence. Nutrients. 2021;13(6). doi: 10.3390/NU13061949. DOI: https://doi.org/10.3390/nu13061949
Storgaard L, Tran TL, Freiberg JC, Hauser AS, Kolko M. Glaucoma clinical research: Trends in treatment strategies and drug development. Front Med. 2021;8. doi: 10.3389/FMED.2021.733080. DOI: https://doi.org/10.3389/fmed.2021.733080
García-Bermúdez MY, Freude KK, Mouhammad ZA, van Wijngaarden P, Martin KK, Kolko M. Glial cells in glaucoma: Friends, foes, and potential therapeutic targets. Front Neurol. 2021;12. doi: 10.3389/FNEUR.2021.624983. DOI: https://doi.org/10.3389/fneur.2021.624983
Garcia GA, Ngai P, Mosaed S, Lin KY. Critical evaluation of latanoprostene bunod in the treatment of glaucoma. Clin Ophthalmol. 2016;10:2035-2050. doi: 10.2147/OPTH.S103985. DOI: https://doi.org/10.2147/OPTH.S103985
Mincione F, Nocentini A, Supuran CT. Advances in the discovery of novel agents for the treatment of glaucoma. Expert Opin Drug Discov. 2021;16(10):1209-1225. doi: 10.1080/17460441.2021.1922384. DOI: https://doi.org/10.1080/17460441.2021.1922384
Lusthaus J, Goldberg I. Current management of glaucoma. Med J Aust. 2019;210(4):180-187. doi: 10.5694/MJA2.50020. DOI: https://doi.org/10.5694/mja2.50020
Hommer A. [Combination therapy in the medical treatment of glaucoma]. Klin Monbl Augenheilkd. 2013;230(2):133-140. doi: 10.1055/S-0032-1328095. DOI: https://doi.org/10.1055/s-0032-1328095
Welge-Lussen U, Weise S, Lyu A. Assessing the adherence behavior of glaucoma patients to topical eye drops. Patient Prefer Adhere. 2015;9:17. doi: 10.2147/PPA.S69943. DOI: https://doi.org/10.2147/PPA.S69943
Tekin S, Seven E, Öcal H, Batur M, Özer MD, Yaşar T. Adherence to drop treatment in glaucoma patients and its relationship with progression. J Glaucoma Cataract. 2021;16(2):83. doi: 10.37844/GLAUC.CAT.2021.16.14. DOI: https://doi.org/10.37844/glauc.cat.2021.16.14
Banayot R. Glaucoma medication non-compliance in Hebron, Palestine. Ophthalmol J. 2021;6(0):10-16. doi: 10.5603/OJ.2021.0003. DOI: https://doi.org/10.5603/OJ.2021.0003
Sharma R, Singhal D, Shashni A, Agarwal E, Wadhwani M, Dada T. Comparison of eye drop instillation before and after use of drop application strips in glaucoma patients on chronic topical therapy. J Glaucoma. 2016;25(4):e438-e440. doi: 10.1097/IJG.0000000000000342. DOI: https://doi.org/10.1097/IJG.0000000000000342
Gomes BF, Paredes AF, Madeira N, Moraes HV, Santhiago MR. Assessment of eye drop instillation technique in glaucoma patients. Arq Bras Oftalmol. 2017;80(4):238-241. doi: 10.5935/0004-2749.20170058. DOI: https://doi.org/10.5935/0004-2749.20170058
Atey TM, Shibeshi W, Giorgis AT, Asgedom SW. The impact of adherence and instillation proficiency of topical glaucoma medications on intraocular pressure. J Ophthalmol. 2017;2017. doi: 10.1155/2017/1683430. DOI: https://doi.org/10.1155/2017/1683430
Zhu CQ, Sadlak N, Fiorello MG, Lee D, Desai M. A comparison of patient acceptance of 3 eye drop instillation aids. J Glaucoma. 2021;30(8):725-731. doi: 10.1097/IJG.0000000000001891. DOI: https://doi.org/10.1097/IJG.0000000000001891
Ahmed ZA, Abdallah ZA, Aziz TA. Exploring the role of clinical pharmacist intervention on the outcomes of patients with type 2 diabetes mellitus. J Sulaimani Med Coll. 2020;10(3):395-403. doi: 10.17656/JSMC.10280. DOI: https://doi.org/10.17656/jsmc.10280
Baiz HQ, Aziz TA, Sharif DA. Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers. Al Mustansiriyah J Pharm Sci. 2020;20(1):82-94. doi: 10.32947/AJPS.V20I1.689. DOI: https://doi.org/10.32947/ajps.v20i1.689
Nori DO, Aziz TA, Hussain SA. Medication errors in pediatric hospitals. Am J Pharm Pharmacol. 2014;1(4):56-61.
Chanekar SN, Usgaonkar UPS, Akarkar SO. Ocular surface disease in glaucoma patients on topical medications and its relation to duration of treatment and number of medications. J Clin Ophthalmol Res. 2022;10(2):55. doi: 10.4103/JCOR.JCOR_203_20. DOI: https://doi.org/10.4103/jcor.jcor_203_20
Kim S, Tong B, Lee J, Borodge D, Kooner K. Lifestyle Counseling for Medication Adherence in Glaucoma. Clin Ophthalmol. 2021;15:3521. doi: 10.2147/OPTH.S321351. DOI: https://doi.org/10.2147/OPTH.S321351
Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15(3):90-96. doi: 10.1111/j.1751-7117.2000.tb00211.x. DOI: https://doi.org/10.1111/j.1751-7117.2000.tb00211.x
Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63(3):299-306. doi: 10.1016/J.JCLINEPI.2009.06.011. DOI: https://doi.org/10.1016/j.jclinepi.2009.06.011
Niriayo YL, Kumela K, Kassa TD, Angamo MT. Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia. PLoS One. 2018;13(10). doi: 10.1371/JOURNAL.PONE.0206120. DOI: https://doi.org/10.1371/journal.pone.0206120
Siswoyo S, Kushariyadi K, Sukma BA. Relationship of family support with quality of life in glaucoma patients. NurseLine J. 2021;6(2):89-96. doi: 10.19184/NLJ.V6I2.19847. DOI: https://doi.org/10.19184/nlj.v6i2.19847
Goldberg I, Clement CI, Chiang TH, Walt JG, Lee LJ, Graham S, et al. Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire. J Glaucoma. 2009;18(1):6-12. doi: 10.1097/IJG.0b013e3181752c83. DOI: https://doi.org/10.1097/IJG.0b013e3181752c83
Mourão AOM, Ferreira WR, Martins MAP, et al. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm. 2013;35(1):79-86. doi: 10.1007/S11096-012-9710-7. DOI: https://doi.org/10.1007/s11096-012-9710-7
Strand L, Cipolle R, Morley P, Frakes M. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des. 2004;10(31):3987-4001. doi: 10.2174/1381612043382576. DOI: https://doi.org/10.2174/1381612043382576
McVeigh KA, Vakros G. The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clin Ophthalmol. 2015;9:813-819. doi: 10.2147/OPTH.S82909. DOI: https://doi.org/10.2147/OPTH.S82909
Najal T, Chandrakumar STS, Gnanakarunyan TJ, Thuvaragan S. Bacterial contamination of used eye drops and knowledge on safe usage among glaucoma patients at tertiary hospital, Sri Lanka. GARI Int J Multidiscipl Res. 2020;6(5):76-85.
Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2012;21(3):189-192. doi: 10.1097/IJG.0B013E31820BD2E1. DOI: https://doi.org/10.1097/IJG.0b013e31820bd2e1
Gao X, Yang Q, Huang W, et al. Evaluating eye drop instillation technique and its determinants in glaucoma patients. J Ophthalmol. 2018;2018. doi: 10.1155/2018/1376020. DOI: https://doi.org/10.1155/2018/1376020
Ikeda H. Practice of pharmaceutical care-therapeutic drug monitoring and pharmacoeconomics of glaucoma. Yakugaku Zasshi. 2007;127(9):1441-1448. doi: 10.1248/YAKUSHI.127.1441. DOI: https://doi.org/10.1248/yakushi.127.1441
Bubalo J, Clark RK, Jiing SS, Johnson NB, Miller KA, Clemens-Shipman CJ, et al. Medication adherence: pharmacist perspective. J Am Pharm Assoc (2003). 2010;50(3):394-406. doi: 10.1331/JAPhA.2010.08180. DOI: https://doi.org/10.1331/JAPhA.2010.08180
Lui MH, Lam JC, Kwong YL, Wong TS, Cheung PL, Lai SS, et al. A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population. Int J Ophthalmol. 2017;10(2):293-299. doi: 10.18240/ijo.2017.02.18. DOI: https://doi.org/10.18240/ijo.2017.02.18
Kim CY, Park KH, Ahn J, Ahn MD, Cha SC, Kim HS, et al. Treatment patterns and medication adherence of patients with glaucoma in South Korea. Br J Ophthalmol. 2017;101(6):801-807. doi: 10.1136/bjophthalmol-2016-308505. DOI: https://doi.org/10.1136/bjophthalmol-2016-308505
Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, et al. The most common barriers to glaucoma medication adherence: A cross-sectional survey. Ophthalmology. 2015;122(7):1308-1316. doi: 10.1016/j.ophtha.2015.03.026. DOI: https://doi.org/10.1016/j.ophtha.2015.03.026
Djafari F, Lesk MR, Harasymowycz PJ, Desjardins D, Lachaine J. Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma. 2009;18(3):238-242. doi: 10.1097/IJG.0B013E3181815421. DOI: https://doi.org/10.1097/IJG.0b013e3181815421
Aleem A, Amin F, Asim MH, Farooq N, Arshad S, Raziq M. Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population. Eur J Hosp Pharm. 2021;28(e1):e191-e196. doi: 10.1136/EJHPHARM-2021-002788. DOI: https://doi.org/10.1136/ejhpharm-2021-002788
Rajurkar K, Dubey S, Gupta PP, John D, Chauhan L. Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol. 2018;30(2):125-129. doi: 10.1016/J.JOCO.2017.09.002. DOI: https://doi.org/10.1016/j.joco.2017.09.002
Thomas D. Clinical Pharmacy Education, Practice and Research: Clinical Pharmacy, Drug Information, Pharmacovigilance, Pharmacoeconomics and Clinical Research.; 2018. Accessed September 16, 2019. https://books.google.ae/books?id=9Jp7DwAAQBAJ&pg=PA1&dq=Clinical+Pharmacy+Education,+Practice+and+Research&hl=en&sa=X&ved=0ahUKEwjXtvmywp7fAhWITBUIHXQaCcQQ6AEIKjAA#v=onepage&q=Clinical_Pharmacy_Education%2C_Practice_and_Research&f=false
Nori DO, Aziz TA, Hussain SA. Drug related problems in Sulaimani Pediatric Teaching Hospital, Iraq. World J Pharm Sci. 2014;2(6):534-538.
Leguelinel-Blache G, Dubois F, Bouvet S, Roux-Marson C, Arnaud F, Castelli C, et al. Improving patient's primary medication adherence: The value of pharmaceutical counseling. Medicine (Baltimore). 2015;94(41):e1805. doi: 10.1097/MD.0000000000001805. DOI: https://doi.org/10.1097/MD.0000000000001805
Sanii Y, Torkamandi H, Gholami K, Hadavand N, Javadi M. Role of pharmacist counseling in pharmacotherapy quality improvement. J Res Pharm Pract. 2016;5(2):132. doi: 10.4103/2279-042X.179580. DOI: https://doi.org/10.4103/2279-042X.179580
Bhagat PR, Trivedi KY. Evaluation and comparison of the safety profile of topical anti-glaucoma drugs in patients of primary open angle glaucoma or ocular hypertension or normal tension glaucoma. Clin Exp Vis Eye Res. 2020;3(2):17-29. doi: 10.15713/INS.CLEVER.51. DOI: https://doi.org/10.15713/ins.clever.51
Denis P. Adverse effects, adherence and cost–benefits in glaucoma treatment. Eur Ophthalmic Rev. 2011;05(02):116. doi: 10.17925/EOR.2011.05.02.116. DOI: https://doi.org/10.17925/EOR.2011.05.02.116
Kan YM, Kho BP, Kong L, Chong QX, Tiong MNJ, Wong LMJ. Eye drop instillation technique among patients with glaucoma and evaluation of pharmacists’ roles in improving their technique: an exploratory study. Int J Pharm Pract. 2022;30(6):520-525. doi: 10.1093/ijpp/riac063. DOI: https://doi.org/10.1093/ijpp/riac063
Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells. Adv Ther. 2011;28(6):501-510. doi: 10.1007/S12325-011-0029-X. DOI: https://doi.org/10.1007/s12325-011-0029-x
Frishman WH, Kowalski M, Nagnur S, Warshafsky S, Sica D. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade. Heart Dis. 2001;3(6):386-397. doi: 10.1097/00132580-200111000-00007. DOI: https://doi.org/10.1097/00132580-200111000-00007
Alzuman SN, Al-Humaidan AS. Clinical pharmacist interventions in refill clinic at tertiary care eye specialist hospital. Saudi Pharm J. 2017;25(1):70-75. doi: 10.1016/J.JSPS.2015.07.002. DOI: https://doi.org/10.1016/j.jsps.2015.07.002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).
